Dietary Xylo-oligosaccharide stimulates intestinal bifidobacteria and lactobacilli but has limited effect on intestinal integrity in rats

BMC Research Notes

Volumn 7, Issue 1, 2014, Pages

  Christensen, Ellen Gerd ^a   Licht, Tine Rask ^a   Leser, Thomas Dyrmann ^b   Bahl, Martin Iain ^a  

^a TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

^b CHR HANSEN A S   (Denmark)

Author keywords

Bifidobacterium; Gut microbiota; Intestinal integrity; Xylooligosaccharides

Indexed keywords

BACTERIAL DNA; CARBOHYDRATE DIET; GLUCURONIC ACID; OCCLUDIN; OCLN PROTEIN, RAT; OLIGOSACCHARIDE; PREBIOTIC AGENT; PROBIOTIC AGENT; RNA 16S; XYLOOLIGOSACCHARIDE;

ADMINISTRATION AND DOSAGE; ANIMAL; BIFIDOBACTERIUM; CARBOHYDRATE DIET; FECES; GENETICS; GROWTH, DEVELOPMENT AND AGING; IMPEDANCE; INTESTINE; LACTOBACILLUS; MALE; METABOLISM; MICROBIOLOGY; PERMEABILITY; RIBOTYPING; TIGHT JUNCTION; TIME; WISTAR RAT;

ANIMALS; BIFIDOBACTERIUM; DIETARY CARBOHYDRATES; DNA, BACTERIAL; ELECTRIC IMPEDANCE; FECES; GLUCURONATES; INTESTINES; LACTOBACILLUS; MALE; OCCLUDIN; OLIGOSACCHARIDES; PERMEABILITY; PREBIOTICS; PROBIOTICS; RATS, WISTAR; RIBOTYPING; RNA, RIBOSOMAL, 16S; TIGHT JUNCTIONS; TIME FACTORS;

EID: 84907428525     PISSN: None     EISSN: 17560500     Source Type: Journal    
DOI: 10.1186/1756-0500-7-660     Document Type: Article

References (51)

1. Gut microbiome and metabolic diseases. Fukuda S, Ohno H, Semin Immunopathol 2014 36 103 114 10.1007/s00281-013-0399-z 24196453
2. In vitro fermentation of sugar beet arabino-oligosaccharides by fecal microbiota obtained from patients with ulcerative colitis to selectively stimulate the growth of Bifidobacterium spp. and Lactobacillus spp. Vigsnaes LK, Holck J, Meyer AS, Licht TR, Appl Environ Microbiol 2011 77 8336 8344 10.1128/AEM.05895-11 21984234
3. Feruloylated and nonferuloylated arabino-oligosaccharides from sugar beet pectin selectively stimulate the growth of Bifidobacterium spp. in human fecal in vitro fermentations. Holck J, Lorentzen A, Vigsnaes LK, Licht TR, Mikkelsen JD, Meyer AS, J Agric Food Chem 2011 59 6511 6519 10.1021/jf200996h 21574556
4. Maximal release of highly bifidogenic soluble dietary fibers from industrial potato pulp by minimal enzymatic treatment. Thomassen LV, Vigsnaes LK, Licht TR, Mikkelsen JD, Meyer AS, Appl Microbiol Biotechnol 2011 90 873 884 10.1007/s00253-011-3092-y 21253720
5. From Probiotics to Prebiotics and a Healthy Digestive System. Gibson GR, J Food Sci 2004 69 141 143
6. Prebiotics. Rastall B, Chemical and functional properties of food components Boca Raton, FL, USA: CRC Press, Sikorski ZE, 3 2007 391 411
7. Intestinal barrier function in health and gastrointestinal disease. Camilleri M, Madsen K, Spiller R, Greenwood-Van MB, Verne GN, Neurogastroenterol Motil 2012 24 503 512 10.1111/j.1365-2982.2012.01921.x 22583600
8. Epithelial barriers in intestinal inflammation. John LJ, Fromm M, Schulzke JD, Antioxid Redox Signal 2011 15 1255 1270 10.1089/ars.2011.3892 21294654
9. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Cani PD, Bibiloni R, Knauf C, Waget A, Neyrinck AM, Delzenne NM, Burcelin R, Diabetes 2008 57 1470 1481 10.2337/db07-1403 18305141
10. Alterations in intestinal permeability. Arrieta MC, Bistritz L, Meddings JB, Gut 2006 55 1512 1520 10.1136/gut.2005.085373 16966705
11. Bifidogenic effect of whole-grain wheat during a 12-week energy-restricted dietary intervention in postmenopausal women. Christensen EG, Licht TR, Kristensen M, Bahl MI, Eur J Clin Nutr 2013 67 1316 1321 10.1038/ejcn.2013.207 24149441
12. Effect of fecal water on an in vitro model of colonic mucosal barrier function. Gill CI, Heavey P, McConville E, Bradbury I, Fassler C, Mueller S, Cresci A, Dore J, Norin E, Rowland I, Nutr Cancer 2007 57 59 65 10.1080/01635580701268220 17516863
13. Xylooligosaccharides (XOS) as an Emerging Prebiotic: Microbial Synthesis, Utilization, Structural Characterization, Bioactive Properties, and Applications. Aachary AA, Prapulla SG, Compr Rev Food Sci F 2011 10 2 16 10.1111/j.1541-4337.2010.00135.x
14. Dietary fructo-oligosaccharides and lactulose inhibit intestinal colonisation but stimulate translocation of salmonella in rats. Bovee-Oudenhoven IM, Ten Bruggencate SJ, Lettink-Wissink ML, van der Meer R, Gut 2003 52 1572 1578 10.1136/gut.52.11.1572 14570725
15. Dietary fructo-oligosaccharides and inulin decrease resistance of rats to salmonella: protective role of calcium. Ten Bruggencate SJ, Bovee-Oudenhoven IM, Lettink-Wissink ML, Katan MB, van der Meer R, Gut 2004 53 530 535 10.1136/gut.2003.023499 15016747
16. Some putative prebiotics increase the severity of Salmonella enterica serovar Typhimurium infection in mice. Petersen A, Heegaard PM, Pedersen AL, Andersen JB, Sørensen RB, Frokiaer H, Lahtinen SJ, Ouwehand AC, Poulsen M, Licht TR, BMC Microbiol 2009 9 245 10.1186/1471-2180-9-245 19948011
17. Analysis of the intestinal microbiota of oligosaccharide fed mice exhibiting reduced resistance to Salmonella infection. Petersen A, Bergström A, Andersen JB, Hansen M, Lahtinen SJ, Wilcks A, Licht TR, Benef Microbes 2010 1 271 281 10.3920/BM2010.0016 21831764
18. Dietary fructooligosaccharides increase intestinal permeability in rats. Ten Bruggencate SJ, Bovee-Oudenhoven IM, Lettink-Wissink ML, van der Meer R, J Nutr 2005 135 837 842 15795444
19. Secreted bioactive factors from Bifidobacterium infantis enhance epithelial cell barrier function. Ewaschuk JB, Diaz H, Meddings L, Diederichs B, Dmytrash A, Backer J, Looijer-van LM, Madsen KL, Am J Physiol Gastrointest Liver Physiol 2008 295 1025 G1034 10.1152/ajpgi.90227.2008 18787064
20. Interaction of Bifidobacterium bifidum LMG13195 with HT29 cells influences regulatory-T-cell-associated chemokine receptor expression. Lopez P, Gonzalez-Rodriguez I, Sanchez B, Ruas-Madiedo P, Suarez A, Margolles A, Gueimonde M, Appl Environ Microbiol 2012 78 2850 2857 10.1128/AEM.07581-11 22344636
21. Intestinal mucosal adherence and translocation of commensal bacteria at the early onset of type 2 diabetes: molecular mechanisms and probiotic treatment. Amar J, Chabo C, Waget A, Klopp P, Vachoux C, Bermudez-Humaran LG, Smirnova N, Berge M, Sulpice T, Lahtinen S, Ouwehand A, Langella P, Rautonen N, Sansonetti PJ, Burcelin R, EMBO Mol Med 2011 3 559 572 10.1002/emmm.201100159 21735552
22. Bifidobacteria stabilize claudins at tight junctions and prevent intestinal barrier dysfunction in mouse necrotizing enterocolitis. Bergmann KR, Liu SX, Tian R, Kushnir A, Turner JR, Li HL, Chou PM, Weber CR, De P,I, Am J Pathol 2013 182 1595 1606 10.1016/j.ajpath.2013.01.013 23470164
23. Basic local alignment search tool. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ, J Mol Biol 1990 215 403 410 10.1016/S0022-2836(05)80360-2 2231712
24. Quantification of Bifidobacterium spp., Escherichia coli and Clostridium difficile in faecal samples of breast-fed and formula-fed infants by real-time PCR. Penders J, Vink C, Driessen C, London N, Thijs C, Stobberingh EE, FEMS Microbiol Lett 2005 243 141 147 10.1016/j.femsle.2004.11.052 15668012
25. Detection of Lactobacillus, Pediococcus, Leuconostoc, and Weissella species in human feces by using group-specific PCR primers and denaturing gradient gel electrophoresis. Walter J, Hertel C, Tannock GW, Lis CM, Munro K, Hammes WP, Appl Environ Microbiol 2001 67 2578 2585 10.1128/AEM.67.6.2578-2585.2001 11375166
26. Molecular diversity of Lactobacillus spp. and other lactic acid bacteria in the human intestine as determined by specific amplification of 16S ribosomal DNA. Heilig HG, Zoetendal EG, Vaughan EE, Marteau P, Akkermans AD, de Vos WM, Appl Environ Microbiol 2002 68 114 123 10.1128/AEM.68.1.114-123.2002 11772617
27. Intestinal integrity and Akkermansia muciniphila, a mucin-degrading member of the intestinal microbiota present in infants, adults, and the elderly. Collado MC, Derrien M, Isolauri E, de Vos WM, Salminen S, Appl Environ Microbiol 2007 73 7767 7770 10.1128/AEM.01477-07 17933936
28. Detection and identification of gastrointestinal Lactobacillus species by using denaturing gradient gel electrophoresis and species-specific PCR primers. Walter J, Tannock GW, Tilsala-Timisjarvi A, Rodtong S, Loach DM, Munro K, Alatossava T, Appl Environ Microbiol 2000 66 297 303 10.1128/AEM.66.1.297-303.2000 10618239
29. Altered expression of matrix metalloproteinases and tight junction proteins in rats following PEMF-induced BBB permeability change. Zhang YM, Zhou Y, Qiu LB, Ding GR, Pang XF, Biomed Environ Sci 2012 25 197 202 22998827
30. Butyrate enhances intestinal epithelial barrier function via up-regulation of tight junction protein Claudin-1 transcription. Wang HB, Wang PY, Wang X, Wan YL, Liu YC, Dig Dis Sci 2012 57 3126 3135 10.1007/s10620-012-2259-4 22684624
31. Repeated exposure to water immersion stress reduces the Muc2 gene level in the rat colon via two distinct mechanisms. Shigeshiro M, Tanabe S, Suzuki T, Brain Behav Immun 2012 26 1061 1065 10.1016/j.bbi.2012.05.016 22683765
32. Changes in protein and mRNA expression levels of claudin family after mucosal lesion by intestinal ischemia/reperfusion. Takizawa Y, Kishimoto H, Kitazato T, Tomita M, Hayashi M, Int J Pharm 2012 426 82 89 10.1016/j.ijpharm.2012.01.023 22285474
33. Assessing the fecal microbiota: an optimized ion torrent 16S rRNA gene-based analysis protocol. Milani C, Hevia A, Foroni E, Duranti S, Turroni F, Lugli GA, Sanchez B, Martin R, Gueimonde M, van SD, Margolles A, Ventura M, PLoS One 2013 8 68739 10.1371/journal.pone.0068739 23869230
34. Naive Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy. Wang Q, Garrity GM, Tiedje JM, Cole JR, Appl Environ Microbiol 2007 73 5261 5267 10.1128/AEM.00062-07 17586664
35. Comparative analysis of pyrosequencing and a phylogenetic microarray for exploring microbial community structures in the human distal intestine. Claesson MJ, O'Sullivan O, Wang Q, Nikkila J, Marchesi JR, Smidt H, de Vos WM, Ross RP, O'Toole PW, PLoS One 2009 4 6669 10.1371/journal.pone.0006669 19693277
36. Amplification efficiency: linking baseline and bias in the analysis of quantitative PCR data. Ruijter JM, Ramakers C, Hoogaars WM, Karlen Y, Bakker O, van den Hoff MJ, Moorman AF, Nucleic Acids Res 2009 37 45 10.1093/nar/gkp045 19237396
37. Statistical methods for detecting differentially abundant features in clinical metagenomic samples. White JR, Nagarajan N, Pop M, PLoS Comput Biol 2009 5 1000352 10.1371/journal.pcbi.1000352 19360128
38. Enterotypes of the human gut microbiome. Arumugam M, Raes J, Pelletier E, Le PD, Yamada T, Mende DR, Fernandes GR, Tap J, Bruls T, Batto JM, Bertalan M, Borruel N, Casellas F, Fernandez L, Gautier L, Hansen T, Hattori M, Hayashi T, Kleerebezem M, Kurokawa K, Leclerc M, Levenez F, Manichanh C, Nielsen HB, Nielsen T, Pons N, Poulain J, Qin J, Sicheritz-Ponten T, Tims S, et al. Nature 2011 473 174 180 10.1038/nature09944 21508958
39. Selected indigestible oligosaccharides affect large bowel mass, cecal and fecal short-chain fatty acids, pH and microflora in rats. Campbell JM, Fahey GC Jr, Wolf BW, J Nutr 1997 127 130 136 9040556
40. Impact of Bifidobacterium bifidum MIMBb75 on mouse intestinal microorganisms. Singh N, Arioli S, Wang A, Villa CR, Jahani R, Song YS, Mora D, Guglielmetti S, Comelli EM, FEMS Microbiol Ecol 2013 85 369 375 10.1111/1574-6941.12124 23551062
41. Interactions and competition within the microbial community of the human colon: links between diet and health. Flint HJ, Duncan SH, Scott KP, Louis P, Environ Microbiol 2007 9 1101 1111 10.1111/j.1462-2920.2007.01281.x 17472627
42. Glycobiome: bacteria and mucus at the epithelial interface. Ouwerkerk JP, de Vos WM, Belzer C, Best Pract Res Clin Gastroenterol 2013 27 25 38 10.1016/j.bpg.2013.03.001 23768550
43. Akkermansia muciniphila gen. nov., sp. nov., a human intestinal mucin-degrading bacterium. Derrien M, Vaughan EE, Plugge CM, de Vos WM, Int J Syst Evol Microbiol 2004 54 1469 1476 10.1099/ijs.0.02873-0 15388697
44. Gram-negative bacteria account for main differences between faecal microbiota from patients with ulcerative colitis and healthy controls. Vigsnaes LK, Brynskov J, Steenholdt C, Wilcks A, Licht TR, Benef Microbes 2012 3 287 297 10.3920/BM2012.0018 22968374
45. Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Everard A, Belzer C, Geurts L, Ouwerkerk JP, Druart C, Bindels LB, Guiot Y, Derrien M, Muccioli GG, Delzenne NM, de Vos WM, Cani PD, Proc Natl Acad Sci U S A 2013 110 9066 9071 10.1073/pnas.1219451110 23671105
46. Dietary fructo-oligosaccharides dose-dependently increase translocation of salmonella in rats. Ten Bruggencate SJ, Bovee-Oudenhoven IM, Lettink-Wissink ML, van der Meer R, J Nutr 2003 133 2313 2318 12840199
47. Dietary fructooligosaccharides affect intestinal barrier function in healthy men. Ten Bruggencate SJ, Bovee-Oudenhoven IM, Lettink-Wissink ML, Katan MB, van der Meer R, J Nutr 2006 136 70 74 16365061
48. Tight junction pore and leak pathways: a dynamic duo. Shen L, Weber CR, Raleigh DR, Yu D, Turner JR, Annu Rev Physiol 2011 73 283 309 10.1146/annurev-physiol-012110-142150 20936941
49. Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Cani PD, Possemiers S, Van de WT, Guiot Y, Everard A, Rottier O, Geurts L, Naslain D, Neyrinck A, Lambert DM, Muccioli GG, Delzenne NM, Gut 2009 58 1091 1103 10.1136/gut.2008.165886 19240062
50. Bifidobacteria can protect from enteropathogenic infection through production of acetate. Fukuda S, Toh H, Hase K, Oshima K, Nakanishi Y, Yoshimura K, Tobe T, Clarke JM, Topping DL, Suzuki T, Taylor TD, Itoh K, Kikuchi J, Morita H, Hattori M, Ohno H, Nature 2011 469 543 547 10.1038/nature09646 21270894
51. Effects of fermentation products of pro- and prebiotics on trans-epithelial electrical resistance in an in vitro model of the colon. Commane DM, Shortt CT, Silvi S, Cresci A, Hughes RM, Rowland IR, Nutr Cancer 2005 51 102 109 10.1207/s15327914nc510114 15749636